[
  {
    "ts": "2025-10-30T23:11:20+00:00",
    "headline": "CVS Health (CVS) Margin Miss Reinforces Debate Over Profitability Recovery Prospects",
    "summary": "CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...",
    "url": "https://finance.yahoo.com/news/cvs-health-cvs-margin-miss-231120088.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "27739bbd-e66d-3159-9e07-dbb9eae0ed1c",
      "content": {
        "id": "27739bbd-e66d-3159-9e07-dbb9eae0ed1c",
        "contentType": "STORY",
        "title": "CVS Health (CVS) Margin Miss Reinforces Debate Over Profitability Recovery Prospects",
        "description": "",
        "summary": "CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...",
        "pubDate": "2025-10-30T23:11:20Z",
        "displayTime": "2025-10-30T23:11:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/az3maBuei.SURwtIZ4ic4A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cKBGpv3s0tfaq.7ZzVUgPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b281afd73848ff2f053c086d0c5a15e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-cvs-margin-miss-231120088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-cvs-margin-miss-231120088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T21:51:46+00:00",
    "headline": "CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results",
    "summary": "A strong quarter clouded by one costly accounting charge.",
    "url": "https://finance.yahoo.com/news/cvs-stock-slips-5-7-215146933.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "7d34b2c7-67d7-3507-a940-52b96302efd1",
      "content": {
        "id": "7d34b2c7-67d7-3507-a940-52b96302efd1",
        "contentType": "STORY",
        "title": "CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results",
        "description": "",
        "summary": "A strong quarter clouded by one costly accounting charge.",
        "pubDate": "2025-10-30T21:51:46Z",
        "displayTime": "2025-10-30T21:51:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/a6784f632bebecac7e4babbf500c2c54",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VRk2Bl1Yvd9SHevf84fmcA--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a6784f632bebecac7e4babbf500c2c54.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zzrwpPLlK.CXFoknLjshqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a6784f632bebecac7e4babbf500c2c54.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-stock-slips-5-7-215146933.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-stock-slips-5-7-215146933.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:45:00+00:00",
    "headline": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
    "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
    "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-3f6378ed?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "a6db1552-53ac-36a2-8075-a1ec798bdd7d",
      "content": {
        "id": "a6db1552-53ac-36a2-8075-a1ec798bdd7d",
        "contentType": "STORY",
        "title": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
        "description": "",
        "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
        "pubDate": "2025-10-30T20:45:00Z",
        "displayTime": "2025-10-30T20:45:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a6db1552-53ac-36a2-8075-a1ec798bdd7d/gilead-earnings-beat.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lxAbvrE0N.9JQxx77LMIOw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QFeKSxOPTxwP4Wx0g8tz1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-3f6378ed?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T19:51:11+00:00",
    "headline": "Meta Sells $30 Billion of Bonds as AI Frenzy Fuels Record Orders",
    "summary": "The bond sale comes a day after Chief Executive Officer Mark Zuckerberg warned that the company would spend even more aggressively on artificial intelligence in the coming year.  Morgan Stanley expects big tech companies known as hyperscalers to spend about $3 trillion on infrastructure like data centers between now and the end of 2028, with roughly half of that likely financed through the corporations’ cash flows.  Thursday’s bond sale is the biggest high-grade note offering since 2023, when Pfizer Inc. sold $31 billion of debt.",
    "url": "https://finance.yahoo.com/news/meta-looks-raise-least-25-125032475.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "7884f9cc-3a70-36d5-af58-733a4561e81e",
      "content": {
        "id": "7884f9cc-3a70-36d5-af58-733a4561e81e",
        "contentType": "STORY",
        "title": "Meta Sells $30 Billion of Bonds as AI Frenzy Fuels Record Orders",
        "description": "",
        "summary": "The bond sale comes a day after Chief Executive Officer Mark Zuckerberg warned that the company would spend even more aggressively on artificial intelligence in the coming year.  Morgan Stanley expects big tech companies known as hyperscalers to spend about $3 trillion on infrastructure like data centers between now and the end of 2028, with roughly half of that likely financed through the corporations’ cash flows.  Thursday’s bond sale is the biggest high-grade note offering since 2023, when Pfizer Inc. sold $31 billion of debt.",
        "pubDate": "2025-10-30T19:51:11Z",
        "displayTime": "2025-10-30T19:51:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/e95313af6c2eab8269291183cec134f9",
          "originalWidth": 960,
          "originalHeight": 539,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iLlXzQog9VHFywE2Mt0RZA--~B/aD01Mzk7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/e95313af6c2eab8269291183cec134f9.cf.webp",
              "width": 960,
              "height": 539,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xJsQWvDd8SgttjAn85wWaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/e95313af6c2eab8269291183cec134f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/meta-looks-raise-least-25-125032475.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/meta-looks-raise-least-25-125032475.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "META"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T19:35:43+00:00",
    "headline": "Why CVS Health (CVS) Stock Is Falling Today",
    "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.",
    "url": "https://finance.yahoo.com/news/why-cvs-health-cvs-stock-193543419.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "29e09b51-41b0-3219-a03b-cce943c9d1fb",
      "content": {
        "id": "29e09b51-41b0-3219-a03b-cce943c9d1fb",
        "contentType": "STORY",
        "title": "Why CVS Health (CVS) Stock Is Falling Today",
        "description": "",
        "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.",
        "pubDate": "2025-10-30T19:35:43Z",
        "displayTime": "2025-10-30T19:35:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CVS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TljU2TKBBw.om82sijmNHg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdlNJA5IleaBBwQa3TKTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-cvs-health-cvs-stock-193543419.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-cvs-health-cvs-stock-193543419.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T17:25:20+00:00",
    "headline": "Meta’s bond sale reportedly attracts record $125 billion in orders",
    "summary": "Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.",
    "url": "https://finance.yahoo.com/news/meta-bond-sale-reportedly-attracts-172520531.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "94ca9567-d519-3643-abb7-18cd95281d06",
      "content": {
        "id": "94ca9567-d519-3643-abb7-18cd95281d06",
        "contentType": "STORY",
        "title": "Meta’s bond sale reportedly attracts record $125 billion in orders",
        "description": "",
        "summary": "Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.",
        "pubDate": "2025-10-30T17:25:20Z",
        "displayTime": "2025-10-30T17:25:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/meta-bond-sale-reportedly-attracts-172520531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/meta-bond-sale-reportedly-attracts-172520531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "META"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T15:53:57+00:00",
    "headline": "CVS Health's 'Strong' Q3 Performance Supports Leading Position as Medicare Advantage Carrier, RBC Says",
    "summary": "CVS Health's (CVS) \"strong\" Q3 performance reinforces the company's position as a leading Medicare A",
    "url": "https://finance.yahoo.com/news/cvs-health-apos-apos-strong-155357849.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "717bc815-0686-3635-b2c2-30a0c9a3cbb0",
      "content": {
        "id": "717bc815-0686-3635-b2c2-30a0c9a3cbb0",
        "contentType": "STORY",
        "title": "CVS Health's 'Strong' Q3 Performance Supports Leading Position as Medicare Advantage Carrier, RBC Says",
        "description": "",
        "summary": "CVS Health's (CVS) \"strong\" Q3 performance reinforces the company's position as a leading Medicare A",
        "pubDate": "2025-10-30T15:53:57Z",
        "displayTime": "2025-10-30T15:53:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-apos-apos-strong-155357849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-health-apos-apos-strong-155357849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T14:52:00+00:00",
    "headline": "Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services",
    "summary": "The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.",
    "url": "https://www.barrons.com/articles/cigna-earnings-stock-price-c15099ea?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "02595f32-d039-3f6b-92c6-309f6078a43f",
      "content": {
        "id": "02595f32-d039-3f6b-92c6-309f6078a43f",
        "contentType": "STORY",
        "title": "Cigna Stock Tumbles on Margin Warning for Pharmacy Benefit Services",
        "description": "",
        "summary": "The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.",
        "pubDate": "2025-10-30T14:52:00Z",
        "displayTime": "2025-10-30T14:52:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/02595f32-d039-3f6b-92c6-309f6078a43f/cigna-stock-tumbles-on-margin.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/14f624b00b030b1e46593324b40e16c4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5rTBv7qUqCOBJ9ysDYB3tA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/14f624b00b030b1e46593324b40e16c4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hQdC3jc7zm4qQIyXopLbuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/14f624b00b030b1e46593324b40e16c4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/cigna-earnings-stock-price-c15099ea?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CI"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "UNH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T11:11:00+00:00",
    "headline": "Americans in their 30s, 40s are getting richer faster than boomers — here’s how they’re outpacing their parents",
    "summary": "It's a turnaround for the 'broke' generation.",
    "url": "https://finance.yahoo.com/news/americans-30s-40s-getting-richer-111100775.html",
    "source": "Moneywise",
    "provider": "yfinance",
    "raw": {
      "id": "b6cb06b3-b04f-38e6-8d2b-1eceb3a34cd6",
      "content": {
        "id": "b6cb06b3-b04f-38e6-8d2b-1eceb3a34cd6",
        "contentType": "STORY",
        "title": "Americans in their 30s, 40s are getting richer faster than boomers — here’s how they’re outpacing their parents",
        "description": "",
        "summary": "It's a turnaround for the 'broke' generation.",
        "pubDate": "2025-10-30T11:11:00Z",
        "displayTime": "2025-10-30T11:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneywise_ecomm_711/79c0a1ebf3d5f7f10f44f6cb131cbfb7",
          "originalWidth": 728,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dq5Nfy7y3GAjMtmqpO882g--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_ecomm_711/79c0a1ebf3d5f7f10f44f6cb131cbfb7.cf.webp",
              "width": 728,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BVInzOsfYPqPOD_5ehPF_A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_ecomm_711/79c0a1ebf3d5f7f10f44f6cb131cbfb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Moneywise",
          "url": "https://moneywise.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/americans-30s-40s-getting-richer-111100775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/americans-30s-40s-getting-richer-111100775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T05:33:41+00:00",
    "headline": "CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook",
    "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/cvs-q3-deep-dive-pharmacy-053341156.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "572013c4-0cd9-3c57-a8ef-74afe773c1f5",
      "content": {
        "id": "572013c4-0cd9-3c57-a8ef-74afe773c1f5",
        "contentType": "STORY",
        "title": "CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook",
        "description": "",
        "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.",
        "pubDate": "2025-10-30T05:33:41Z",
        "displayTime": "2025-10-30T05:33:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CVS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TljU2TKBBw.om82sijmNHg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdlNJA5IleaBBwQa3TKTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cvs-q3-deep-dive-pharmacy-053341156.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cvs-q3-deep-dive-pharmacy-053341156.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T02:03:01+00:00",
    "headline": "UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target",
    "summary": "CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]",
    "url": "https://finance.yahoo.com/news/ubs-turns-more-bullish-cvs-020301713.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8531ca70-b472-3d9c-8f51-7f40d00ffe3f",
      "content": {
        "id": "8531ca70-b472-3d9c-8f51-7f40d00ffe3f",
        "contentType": "STORY",
        "title": "UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target",
        "description": "",
        "summary": "CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]",
        "pubDate": "2025-10-30T02:03:01Z",
        "displayTime": "2025-10-30T02:03:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yrDm7iyVNAagx0oOilifnQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.L_4QVhEk8dUSgrDa_Iag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ubs-turns-more-bullish-cvs-020301713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ubs-turns-more-bullish-cvs-020301713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]